Charles Pendley
- Immunology top 2%
- Psoriasis: Treatment and Pathogenesis 6
- Biosimilars and Bioanalytical Methods 3
- T-cell and B-cell Immunology 3
- Dermatology top 2%
- Dermatology and Skin Diseases 5
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 4
-
- Monoclonal and Polyclonal Antibodies Research 9
- Hematology top 5%
-
- Asthma and respiratory diseases 5
-
- Neuropeptides and Animal Physiology 3
- Co-authors
- Gopi ShankarMary Ann MascelliKathryn E. SteinDaniel E. EverittThomas S. McCormickKevin D. CooperEiko ToichiAlice B. Gottlieb
- Cited by
- ImmunologyDermatologyRheumatology
- Journals
- Journal of Pharmacology and Experimental Therapeutics (4 papers)Nature Biotechnology (2 papers)The Journal of Clinical Pharmacology (2 papers)
- Partner nations
- United StatesBelgiumFrance
In The Last Decade
Charles Pendley
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 119
- Immunology 926
- Dermatology 263
- Rheumatology 283
- Radiology, Nuclear Medicine and Imaging 376
- Hematology 176
Countries citing papers authored by Charles Pendley
This map shows the geographic impact of Charles Pendley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Pendley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Pendley more than expected).
Fields of papers citing papers by Charles Pendley
This network shows the impact of papers produced by Charles Pendley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Pendley. The network helps show where Charles Pendley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles Pendley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 4 | |
| 2 | 2013 | 3 | |
| 3 | 2011 | 104 | |
| 4 | 2010 | 45 | |
| 5 | 2010 | 23 | |
| 6 | 2010 | 45 | |
| 7 | 2007 | 149 | |
| 8 | 2007 | 52 | |
| 9 | 2006 | 168 | |
| 10 | 2006 | 46 | |
| 11 | 2005 | 7 | |
| 12 | 2004 | 212 | |
| 13 | 2004 | 68 | |
| 14 | 1995 | 34 | |
| 15 | 1994 | 10 | |
| 16 | 1994 | 29 | |
| 17 | 1993 | 33 | |
| 18 | 1990 | 17 | |
| 19 | 1989 | 3 | |
| 20 | 1983 | 13 |
About Charles Pendley
Charles Pendley is a scholar working on Dermatology, Immunology, Radiology, Nuclear Medicine and Imaging, Rheumatology and Toxicology, having authored 31 papers that have together received 1.7k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (5 papers), Asthma and respiratory diseases (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Neuropeptides and Animal Physiology (3 papers) and T-cell and B-cell Immunology (3 papers). The work is most often cited by research in Immunology (926 citations), Dermatology (263 citations), Rheumatology (283 citations), Radiology, Nuclear Medicine and Imaging (376 citations) and Hematology (176 citations). Charles Pendley has collaborated with scholars based in United States, Belgium and France. Frequent co-authors include Gopi Shankar, Mary Ann Mascelli, Kathryn E. Stein, Daniel E. Everitt, Thomas S. McCormick, Kevin D. Cooper, Eiko Toichi, Alice B. Gottlieb, Bart Frederick and Honghui Zhou. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Nature Biotechnology, The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.